Rejuvel Bio-Sciences, Inc.
NUUU
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | -43.17% | 48.39% | 161.41% | 50.68% | 2.65% |
| Total Depreciation and Amortization | 68.63% | 76.09% | 72.09% | 60.98% | 27.50% |
| Total Amortization of Deferred Charges | 429.47% | 3.06% | -91.55% | -58.34% | -90.07% |
| Total Other Non-Cash Items | -135.10% | -180.65% | -212.88% | -1,882.30% | 134.78% |
| Change in Net Operating Assets | 43.26% | -0.69% | -47.62% | 1.26% | -16.65% |
| Cash from Operations | -33.86% | -72.91% | -69.04% | -65.73% | -38.30% |
| Capital Expenditure | 100.00% | -39.83% | -83.00% | -83.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 47.00% | -166.95% | -233.00% | -233.00% | -- |
| Total Debt Issued | 222.76% | 524.73% | 96.37% | 19.76% | -22.70% |
| Total Debt Repaid | 12.24% | 31.87% | -45.98% | -87.62% | -326.58% |
| Issuance of Common Stock | -82.39% | 0.63% | 66.24% | -- | -- |
| Repurchase of Common Stock | -770.00% | -- | -- | -- | 98.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -96.45% | -144.42% | -143.58% | -96.59% | -6.70% |
| Cash from Financing | -33.34% | -1.94% | -24.96% | 192.30% | 197.02% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.07% | -187.51% | -184.73% | 129.79% | 268.54% |
